Showing results for "#autoimmune disease lupus"

Obinutuzumab trial yields promising outcomes in patients with lupus...

Over the course of the trial, adding obinutuzumab lowered the incidence of lupus nephritis relapses by 57 per cent and dramatically reduced the rate...